Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Mast Therapeutics raises $25 million in follow-on

Mast Therapeutics Inc. (NYSE-M:MSTX) raised $25 million through the sale

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE